Pelvic floor symptoms in women losing weight
Part of Digestive system, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at how weight loss affects pelvic floor symptoms like bladder or bowel issues. It includes women in a medical weight loss program or planning bariatric surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 18 and 89 years old.
- Your BMI is 30 or higher.
- You are currently a patient in a medical weight loss or bariatric surgery program at Hartford HealthCare.
- You are willing to sign a consent form.
- You have a scale at home to weigh yourself.
- You are not pregnant and have no active cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether weight-loss surgery can improve urinary symptoms like needing to pee often or suddenly. It is for people with severe obesity who are already being seen at a specific clinic for bariatric surgery.
This study tests a 6-month behavioral program (including exercise, diet, and mindfulness) designed to help you keep weight off after stopping GLP-1 or similar weight-loss medications. It's for people who have already lost at least 15% of their body weight and stopped or are stopping these medications.
This study follows people who recently stopped taking a GLP-1 medication (like Wegovy or Ozempic) to understand how weight, eating habits, and daily routines change over time. It aims to help patients and doctors know what to expect after stopping the drug.
This study tests whether switching to an oral weight-loss medication can help you keep off the weight you lost after stopping a GLP-1 injection like semaglutide or tirzepatide. You might qualify if you live in Massachusetts, are between 18 and 80, have a BMI of 30 or higher, lost at least 10% of your body weight on these injections, and are willing to be randomly assigned to a new treatment.
This trial tests whether adding a GLP-1 receptor agonist (a medication that helps control blood sugar and appetite) after weight loss surgery improves outcomes for people with severe obesity and related health problems like type 2 diabetes.
This study looks at what happens when people taking a GLP-1 medication (like Ozempic) either stop or continue it after weight loss surgery. The goal is to learn whether staying on the medicine helps with long-term weight control.
Hear when a new Lower Urinary Tract Symptoms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.